ResMed Inc.

246.14+2.74+1.13%Vol 136.89K1Y Perf 35.22%
Jun 24th, 2021 11:35 DELAYED
BID246.02 ASK246.19
Open244.96 Previous Close243.40
Pre-Market- After-Market-
 - -%  - -
Target Price
221.00 
Analyst Rating
Hold 2.67
Potential %
-10.13 
Finscreener Ranking
     39.66
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
     42.26
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★     60.17
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
★+     35.42
Market Cap35.82B 
Earnings Rating
Sell
Price Range Ratio 52W %
99.19 
Earnings Date
4th Aug 2021

Today's Price Range

244.88246.80

52W Range

165.72246.80

5 Year PE Ratio Range

19.8069.20

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
1.22%
1 Month
17.97%
3 Months
26.65%
6 Months
14.58%
1 Year
35.22%
3 Years
125.52%
5 Years
304.07%
10 Years
770.21%

TickerPriceChg.Chg.%
RMD246.142.74001.13
AAPL133.960.26000.19
GOOG2 542.8413.61000.54
MSFT267.151.87000.70
XOM64.320.06000.09
WFC45.051.09002.48
JNJ163.100.47000.29
FB344.003.41001.00
GE13.010.06000.46
JPM152.251.13000.75
Financial StrengthValueIndustryS&P 500US Markets
0.90
1.70
0.24
0.32
31.80
Leverage Ratio 1.70
ProfitabilityValueIndustryS&P 500US Markets
58.20
28.60
34.80
22.20
14.54
RevenueValueIndustryS&P 500US Markets
3.09B
21.24
9.66
11.26
DividendsValueIndustryS&P 500US Markets
0.65
1.56
3.85
5.59
Payout ratio32.00
Earnings HistoryEstimateReportedSurprise %
Q03 20211.221.306.56
Q02 20211.221.4115.57
Q01 20210.981.2729.59
Q04 20200.971.3337.11
Q03 20201.001.2929.00
Q02 20201.011.2119.80
Q01 20200.870.936.90
Q04 20190.920.953.26
Earnings Per EndEstimateRevision %Trend
6/2021 QR1.28-2.29Negative
6/2021 FY5.28-0.38Negative
9/2021 QR1.25-1.57Negative
6/2022 FY5.59-0.53Negative
Next Report Date4th Aug 2021
Estimated EPS Next Report1.28
Estimates Count4
EPS Growth Next 5 Years %13.90
Volume Overview
Volume136.89K
Shares Outstanding145.52M
Trades Count3.32K
Dollar Volume153.77M
Avg. Volume647.74K
Avg. Weekly Volume579.65K
Avg. Monthly Volume680.19K
Avg. Quarterly Volume616.37K

ResMed Inc. (NYSE: RMD) stock closed at 243.4 per share at the end of the most recent trading day (a 0.96% change compared to the prior day closing price) with a volume of 567.01K shares and market capitalization of 35.82B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 7770 people. ResMed Inc. CEO is Michael J. Farrell.

The one-year performance of ResMed Inc. stock is 35.22%, while year-to-date (YTD) performance is 14.51%. RMD stock has a five-year performance of 304.07%. Its 52-week range is between 165.72 and 246.8, which gives RMD stock a 52-week price range ratio of 99.19%

ResMed Inc. currently has a PE ratio of 75.90, a price-to-book (PB) ratio of 12.75, a price-to-sale (PS) ratio of 11.28, a price to cashflow ratio of 41.30, a PEG ratio of 2.32, a ROA of 8.98%, a ROC of 12.90% and a ROE of 16.60%. The company’s profit margin is 14.54%, its EBITDA margin is 34.80%, and its revenue ttm is $3.09 Billion , which makes it $21.24 revenue per share.

Of the last four earnings reports from ResMed Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.28 for the next earnings report. ResMed Inc.’s next earnings report date is 04th Aug 2021.

The consensus rating of Wall Street analysts for ResMed Inc. is Hold (2.67), with a target price of $221, which is -10.13% compared to the current price. The earnings rating for ResMed Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

ResMed Inc. has a dividend yield of 0.65% with a dividend per share of $1.56 and a payout ratio of 32.00%.

ResMed Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 15.37, ATR14 : 4.98, CCI20 : 112.95, Chaikin Money Flow : 0.13, MACD : 10.81, Money Flow Index : 82.82, ROC : 17.76, RSI : 80.51, STOCH (14,3) : 95.63, STOCH RSI : 0.54, UO : 68.24, Williams %R : -4.37), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of ResMed Inc. in the last 12-months were: Brett A. Sandercock (Sold 32 500 shares of value $6 430 450 ), Brett Sandercock (Sold 2 500 shares of value $492 450 ), David B. Pendarvis (Sold 0 shares of value $-1 809 286 ), David B. Pendarvis (Sold 40 003 shares of value $7 694 236 ), James R. Hollingshead (Sold 28 800 shares of value $5 695 154 ), Justin Leong (Sold 0 shares of value $-447 062 ), Justin Leong (Sold 7 740 shares of value $1 635 926 ), Rajwant Sodhi (Sold 16 500 shares of value $3 217 485 ), Robert Andrew Douglas (Sold 0 shares of value $-931 840 ), Robert Andrew Douglas (Sold 26 336 shares of value $5 423 264 ), Ronald R. Taylor (Sold 4 000 shares of value $800 564 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (33.33 %)
3 (33.33 %)
2 (22.22 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
4 (44.44 %)
4 (44.44 %)
6 (66.67 %)
Moderate Sell
1 (11.11 %)
1 (11.11 %)
1 (11.11 %)
Strong Sell
1 (11.11 %)
1 (11.11 %)
0 (0.00 %)
Summary RatingHold
2.67
Hold
2.67
Hold
2.67

ResMed Inc.

ResMed is one of the largest global respiratory medical devices companies, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns 65% of revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

CEO: Michael J. Farrell

Telephone: +1 858 836-5000

Address: 9001 Spectrum Center Boulevard, San Diego 92123, CA, US

Number of employees: 7 770

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

60%40%

Bearish Bullish

56%44%

Bearish Bullish

61%39%

News

Stocktwits